HomeTagsJohnson & Johnson

Tag: Johnson & Johnson

biotech

First precision therapy prostate cancer drug approved

Jim Cornall - December 17, 2025

biotech

CRS programme to feature Poolbeg Pharma trial

Jim Cornall - December 11, 2025

biotech

“Turning point in how we treat EGFR-mutated lung cancer”

Jim Cornall - September 10, 2025

biotech

Johnson & Johnson aiming to revolutionise plaque psoriasis treatment

Jim Cornall - July 24, 2025

biotech

Johnson & Johnson receives Priority Review for high-risk non-muscle invasive bladder cancer treatment

Jim Cornall - July 22, 2025

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 58: Congenital myotonic dystrophy

biotech

Lab-grown red blood cells cover all blood types

biotech

Researchers discover new therapeutic targets for lithium in Alzheimer’s disease

biotech

New research brings personalised treatment for Parkinson’s disease closer

biotech

Greywolf Therapeutics and Genomics look to develop first‑in‑class autoimmune diseases treatments